|
1
|
Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
|
Nature
|
2004
|
4.35
|
|
2
|
A cluster randomised controlled trial of the effect of a treatment algorithm for hypertension in patients with type 2 diabetes.
|
Br J Gen Pract
|
2007
|
1.64
|
|
3
|
Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice.
|
Nature
|
2007
|
1.54
|
|
4
|
Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group.
|
Pediatr Blood Cancer
|
2008
|
1.49
|
|
5
|
Understanding of blood pressure by people with type 2 diabetes: a primary care focus group study.
|
Br J Gen Pract
|
2005
|
0.94
|
|
6
|
Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action.
|
Pharm Res
|
2011
|
0.92
|
|
7
|
A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893.
|
Pediatr Blood Cancer
|
2012
|
0.91
|
|
8
|
Targeted epidermal expression of mutant Connexin 26(D66H) mimics true Vohwinkel syndrome and provides a model for the pathogenesis of dominant connexin disorders.
|
Hum Mol Genet
|
2003
|
0.91
|
|
9
|
Rapid intradermal delivery of liquid formulations using a hollow microstructured array.
|
Pharm Res
|
2010
|
0.89
|
|
10
|
Safety and efficacy of metallic stents in the management of colorectal obstruction.
|
JSLS
|
2005
|
0.84
|
|
11
|
p21-LacZ reporter mice reflect p53-dependent toxic insult.
|
Toxicol Appl Pharmacol
|
2007
|
0.83
|
|
12
|
Illuminating role of CYP1A1 in skin function.
|
J Invest Dermatol
|
2008
|
0.81
|
|
13
|
Spatial p21 expression profile in the mid-term mouse embryo.
|
Transgenic Res
|
2010
|
0.79
|
|
14
|
Guidelines for the management of head injuries in remote and rural Alaska.
|
Alaska Med
|
2005
|
0.79
|
|
15
|
Peroxiredoxin gene expression signatures in liver reflect toxic insult.
|
Assay Drug Dev Technol
|
2010
|
0.79
|
|
16
|
Spatial monitoring of toxicity in HMOX-LacZ transgenic mice.
|
Transgenic Res
|
2010
|
0.78
|
|
17
|
Adjuvants to prolong the local anesthetic effects of coated microneedle products.
|
Int J Pharm
|
2012
|
0.78
|
|
18
|
Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: a report from the children's oncology group.
|
J Pediatr Surg
|
2010
|
0.77
|
|
19
|
Evaluation of a cardiac prevention and rehabilitation programme for all patients at first presentation with coronary artery disease.
|
J Cardiovasc Risk
|
2002
|
0.77
|
|
20
|
Evaluation of RNA-knockdown strategies for modulation of cytochrome P450 reductase activity in mouse hepatocytes.
|
J RNAi Gene Silencing
|
2010
|
0.76
|
|
21
|
Physicians' perceptions of integration in three Western Canada Health Regions.
|
Healthc Manage Forum
|
2005
|
0.75
|